A retrospective study to assess temporal trends in mortality for colon cancer and non-infective enteritis and colitis among U.S. adults, 1999-2020

Harshita Bedi; Nilay Pawanarkar; Chirag Golani; Deepak Singh; Neeraj Namasivayam

doi:10.18203/2349-2902.isj20263350

Authors

Harshita Bedi Department of Surgery, KS Hedge Medical Academy, Mangaluru, Karnataka, India
Nilay Pawanarkar Department of Surgery, JJM Medical College Davanagere, Karnataka, India
Chirag Golani Department of Surgery, GMERS Medical College, Vadnagar, Gujarat, India
Deepak Singh Department of Surgery, Tbilisi, Georgia73 Chargali St, Tbilisi, Georgia
Neeraj Namasivayam Department of Surgery, Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry, India

DOI:

https://doi.org/10.18203/2349-2902.isj20263350

Keywords:

Colon cancer, Non-infective enteritis/colitis, Mortality trends, United States

Abstract

Background: Colon cancer and non-infective enteritis and colitis continue to be major causes of gastrointestinal deaths in the United States, despite improvements in screening, diagnosis, and treatment. This study to evaluate long-term mortality trends and demographic differences in colon cancer and non-infective enteritis and colitis among U.S. adults aged 25 years and older, between 1999 and 2020.

Methods: In this retrospective, STROBE-compliant study, data was obtained from the CDC Multiple Cause of Death database (1999-2020). Deaths were categorised by colon cancer (C18) as the underlying cause and non-infective enteritis and colitis (K50-K52) as a contributing cause. Age-adjusted mortality rates (per 1,000,000 population) and temporal trends were assessed using Joinpoint regression. Associations with sex, race, urbanization, and place of death were also evaluated.

Results: A total of 2,885 deaths were analyzed. Of these, 53.2% were males and 46.8% females; 92.1% were White and 6.4% Black; 80.9% lived in metropolitan areas, including 27.5% in large central areas. 47.6% of deaths occurred in medical facilities, 28.4% at home, and 13.1% in nursing homes. Mortality rates were higher among males and residents of metropolitan areas. Joinpoint regression revealed significant temporal changes in mortality over the study period.

Conclusions: Mortality from colon cancer and non-infective enteritis/colitis showed changes over time from 1999 to 2020, with overall declines but with higher mortality rates among males and those in metropolitan areas. These findings highlight the importance of improving screening, early detection, and targeted interventions to reduce disparities and improve outcomes in high-risk populations.

References

Kusnik A, Renjithlal SLM, Chodos A, Shanmukhappa SC, Eid MM, Renjith KM, et al. Trends in colorectal cancer mortality in the United States, 1999-2020. Gastroenterol Res. 2023;16(4):217-25.

Tan JY, Yeo YH, Ng WL, Fong ZV, Brady JT. How have US colorectal cancer mortality trends changed in the past 20 years? Int J Cancer. 2024;155(3):493-500.

Javaid SS, Akhtar S, Hafeez A, Nofal A, Rahman S, Farooqui SK, et al. Trends in mortality due to inflammatory bowel disease in the United States: a CDC WONDER database analysis (1999-2020). Dig Dis Sci. 2025;70(2):494-503.

National Cancer Institute. Joinpoint Regression Program. Version 5.3.0. Bethesda (MD): National Cancer Institute. Available at: https://surveillance.cancer.gov/joinpoint. Accessed on 08 July 2026.

Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31-4.

Protection of human subjects, 45 CFR part 46. Code of Federal Regulations. Title 45, Public Welfare. Washington (DC): U.S. Government Publishing Office. Available at: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-46 . Accessed on 08 July 2026.

Office for Human Research Protections. Guidance on research involving coded private information or biological specimens [Internet]. Rockville (MD): U.S. Department of Health and Human Services; 2008 [cited 2026 Jul 16]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/guidance/research-involving-coded-private-information/index.html

Deoghare S. Virtual research designs and IRB requirements: clarifying what truly needs ethics approval. Minerva Med. 2026;117(2):96-7.

Centers for Disease Control and Prevention. Multiple Cause of Death, 1999-2020. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available from: https://wonder.cdc.gov/wonder/help/mcd.html. Accessed on 08 July 2026.

World Health Organization. International statistical classification of diseases and related health problems. 10th revision (ICD-10). Geneva: World Health Organization; 2010. Available from: https://icd.who.int/browse10/2010/en. Accessed on 18 July 2026.

Sorlie PD, Thom TJ, Manolio T, Rosenberg HM, Anderson RN, Burke GL. Age-adjusted death rates: consequences of the year 2000 standard. Ann Epidemiol. 1999;9(2):93-100.

Glisan A, Nielsen E, Billion T, Jabbar AB, Avula A, Mirza M, et al. Regional trends in colorectal cancer mortality in people aged 45-84 years in the US, 1999-2022. J Gastrointest Oncol. 2024;15(6):2533-42.

Doubeni CA, Corley DA, Zhao W, Lau Y, Jensen CD, Levin TR. Association between improved colorectal screening and racial disparities. N Engl J Med. 2022;386(8):796-8.

Appiah JK, Asante R, Asiedu EK, Asiedu E. Two decades of disparity: racial and geographic trends in colorectal cancer mortality in the United States (2000-2020). Cureus. 2025;17(5):e84847.

Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453-63.

Siegel RL, Torre LA, Soerjomataram I, Hayes RB, Bray F, Weber TK, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179-85.

Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017;109(8):djw322.

Chen Y, He L, Lu X, Tang Y, Luo G, Chen Y, et al. Causes of death among early-onset colorectal cancer population in the United States: a large population-based study. Front Oncol. 2023;13:1094493.

Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145-64.

Javaid SS, Akhtar S, Hafeez A, Nofal A, Rahman S, Farooqui SK, et al. Trends in mortality due to inflammatory bowel disease in the United States: a CDC WONDER database analysis (1999-2020). Dig Dis Sci. 2025;70(2):494-503.

Arif TB, Ahmad J, Afzal N, Butt MA, Afzal S, Ahmad F, et al. Temporal trends in mortality related to Crohn's disease in the United States: a 21-year retrospective analysis of CDC-WONDER database. J Clin Gastroenterol. 2026;60(8):735-42.

Wu J, Fang Y, Bai B, Wu Y, Liu Q, Hu J, et al. Clinical characteristics and the risk factors for the exacerbation of symptoms in patients with inflammatory bowel disease during the COVID-19 pandemic. Front Med (Lausanne). 2024;11:1404880.

Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. United European Gastroenterol J. 2021;9(2):159-76.

Zurob S, Brown A, Billion T, Aslam MN, Tauseef A, Mirza M, et al. Regional trends in inflammatory bowel disease-related mortality in the US from 1999 to 2022. Clin Exp Gastroenterol. 2025;18:55-66.

Salem DA, El-Ijla R, AbuMusameh RR, Zakout KA, Abu Halima AY, Abudiab MT, et al. Sex-related differences in profiles and clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol. 2024;24(1):425.

Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M, et al. Impact of female gender in inflammatory bowel diseases: a narrative review. J Pers Med. 2023;13(2):165.

Greuter T, Manser C, Pittet V, Vavricka SR, Biedermann L. Gender differences in inflammatory bowel disease. Digestion. 2020;101(Suppl 1):98-104.

Aniwan S, Harmsen WS, Tremaine WJ, Kane SV, Loftus EV Jr. Overall and cause-specific mortality of inflammatory bowel disease in Olmsted County, Minnesota, from 1970 through 2016. Mayo Clin Proc. 2018;93(10):1415-22.

Sewell JL, Yee HF Jr. Thirteen-year mortality trends among hospitalized patients with inflammatory bowel disease. BMC Gastroenterol. 2012;12:79.